Helius Medical Technologies

Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI | Globe Newswire | 4/30/2020

122 Subject, Multicenter, Double-Blind, Randomized, Clinical Trial Finds PoNS Treatment™ found Significant Improvement in Balance and Gait Deficits for Individuals Who Have Experienced a Mild-to-Moderate Traumatic Brain Injury April 30, 2020 07:05 ET Source: Helius Medical Technologies , Inc. NEWTOWN, Pa., April 30, 2020 (GLOBE NEWSWIRE) – Helius Medical Technologies , Inc. (NASDAQ: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that …

Helius Medical Technologies Appoints Jeffrey S. Mathiesen to its Board of Directors | Globe Newswire | 4/22/2020

NEWTOWN, Pa., April 22, 2020 (GLOBE NEWSWIRE) – Helius Medical Technologies , Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Jeffrey S. Mathiesen, CPA, to its Board of Directors, effective as of June 9, 2020. Upon his appointment, Mr. Mathiesen will serve as Chair of the Company’s Audit Committee. “Jeff joins our Board of Directors with more than 25 …

Follow Helius Medical Technologies:    

Helius Medical Technologies (OTCMKTS:HSDT) Share Price Passes Below 50 Day Moving Average of $0.55 | 4/12/2020

Helius Medical Technologies Inc (OTCMKTS:HSDT) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.55 and traded as low as $0.26. Helius Medical Technologies shares last traded at $0.26, with a volume of 456,135 shares. Separately, Zacks Investment Research upgraded Helius Medical Technologies from a “sell” rating to a “hold” rating in a report on Wednesday, January 15th …

Helius Medical Technologies (OTCMKTS:HSDT) Share Price Crosses Below Fifty Day Moving Average of $0.55 | 4/12/2020

Shares of Helius Medical Technologies Inc (OTCMKTS:HSDT) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.55 and traded as low as $0.26. Helius Medical Technologies shares last traded at $0.26, with a volume of 456,135 shares. Separately, Zacks Investment Research raised Helius Medical Technologies from a “sell” rating to a “hold” rating in a research report on …

Helius Medical Technologies (OTCMKTS:HSDT) Shares Cross Below Fifty Day Moving Average of $0.55 | 4/11/2020

… Technologies Inc (OTCMKTS:HSDT)’s stock price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.55 and traded as low as $0.26. Helius Medical Technologies shares last traded at $0.26, with a volume of 456,135 shares trading hands. Separately, Zacks Investment Research upgraded Helius Medical Technologies from a “sell” rating to a “hold” rating in a research report …

Helius Medical Technologies (HSDT) Gets a Hold Rating from Oppenheimer | 4/10/2020

By Austin Angelo Oppenheimer analyst Steven Lichtman maintained a Hold rating on Helius Medical Technologies ( HSDT – Research Report ) today. The company’s shares closed last Thursday at $0.26, close to its 52-week low of $0.25. According to TipRanks.com , Lichtman is ranked 0 out of 5 stars with an average return of -5.5% and a 48.3% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings …

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO | Benzinga | 4/8/2020

… Masimo Corporation (NASDAQ: MASI ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows April 7) Celcuity Inc (NASDAQ: CELC ) Curis, Inc. (NASDAQ: CRIS ) Helius Medical Technologies Inc (NASDAQ: HSDT ) Menlo Therapeutics Inc (NASDAQ: MNLO ) TherapeuticsMD Inc (NASDAQ: TXMD ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) Stocks In Focus COVID-19 Test Sales to Lift GenMark’s Q1 Results; Company Raises 2020 Guidance …

Edited Transcript of HSM.TO earnings conference call or presentation 12-Mar-20 9:00pm GMT | Yahoo News | 3/29/2020

Operator [1] Good evening, ladies and gentlemen. And welcome to the Fourth Quarter Fiscal Year 2019 Earnings Conference Call for Helius Medical Technologies . (Operator Instructions) Please note this conference call is being recorded and that the recording will be available on the company’s website for replay shortly. Before we begin, I’d like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that …

Helius Medical Technologies (OTCMKTS:HSDT) Stock Price Up 8.3% | 3/28/2020

Shares of Helius Medical Technologies Inc (OTCMKTS:HSDT) rose 8.3% on Thursday . The stock traded as high as $0.36 and last traded at $0.34, approximately 1,376,735 shares were traded during trading. An increase of 372% from the average daily volume of 291,620 shares. The stock had previously closed at $0.31. Separately, Zacks Investment Research upgraded Helius Medical Technologies from a “sell” rating to a “hold” rating in a research report …

Helius Medical Technologies Authorized by Heath Canada to Market PoNS Device | 3/26/2020

4.5 ( 35 ) The neurotechnology company Helius Medical Technologies has received authorization from Health Canada to market its portable neuromodulation stimulator (PoNS) device to treat gait deficit in patients with mild-to-moderate multiple sclerosis (MS). The symptoms and severity of MS differ between patients, although functional limitations such as gait dysfunction (difficulty walking) are common. Gait difficulties often result from fatigue , muscle weakness, muscle tightness ( spasticity ), loss of balance, and …

Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS™ Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS) | Globe Newswire | 3/24/2020

NEWTOWN, Pa., Helius Medical Technologies , Inc. (NASDAQ: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), today announced that its Canadian Class II license amendment application for the treatment of gait deficit in patients with mild and moderate symptoms from multiple sclerosis (“MS”) has received marketing authorization from Health Canada. Helius’ Portable Neuromodulation Stimulator (PoNS™) device is now authorized to be marketed for the short-term treatment (14 weeks) of gait deficit …

Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS) | Financial Buzz | 3/24/2020

NEWTOWN, Pa., Helius Medical Technologies , Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), today announced that its Canadian Class II license amendment application for the treatment of gait deficit in patients with mild and moderate symptoms from multiple sclerosis (“MS”) has received marketing authorization from Health Canada. Helius’ Portable Neuromodulation Stimulator (PoNS™) device is now authorized to be marketed for the short-term treatment (14 weeks) of gait deficit …

Helius Medical Technologies (OTCMKTS:HSDT) Shares Up 5.8% - Ticker Report | 3/22/2020

… company traded as high as $0.32 and last traded at $0.32, 643,483 shares were traded during trading. An increase of 155% from the average session volume of 252,140 $0.30. Separately, Zacks Investment Research raised Helius Medical Technologies from a “sell” report on Wednesday, January 15th. Get Helius Medical Technologies alerts: The business has a fifty day simple moving average of $0.80 and a 200 day simple moving average of $1.08 …

Helius Medical Technologies (OTCMKTS:HSDT) Shares Pass Below Fifty Day Moving Average of $0.80 - TheOlympiaReport | 3/22/2020

Shares of Helius Medical Technologies Inc (OTCMKTS:HSDT) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.80 and traded as low as $0.28. Helius Medical Technologies shares last traded at $0.32, with a volume of 643,483 shares traded. Separately, Zacks Investment Research raised shares of Helius Medical Technologies from a “sell” rating to a “hold” report on Wednesday …

Helius Medical Technologies Announces $2.2 Million Registered Direct Offering | Globe Newswire | 3/18/2020

NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) – Helius Medical Technologies , Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that it has entered into definitive agreements with healthcare focused institutional investors that provide for the purchase and sale of an aggregate of 6,257,144 shares of its Class A Common Stock, or common stock, at a purchase price of $0.35 per share …

Google Alert - NASDAQ | 3/16/2020

… Your Attention Today Yahoo Finance In the age of tech-stock blue-sky investing, my choice may seem old fashioned; I still prefer profitable companies like County Bancorp ( NASDAQ :ICBK) … Flag as irrelevant Can Helius Medical Technologies ( NASDAQ :HSDT) Fund Its Growth Plans? Yahoo Finance So should Helius Medical Technologies ( NASDAQ :HSDT) shareholders be worried about its cash burn? In this report, we will consider the company’s … Flag as irrelevant …

Helius Medical Technologies (OTCMKTS:HSDT) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS | Daily Political | 3/14/2020

… earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.02, Bloomberg Earnings reports. The firm had revenue of $0.15 million during the quarter, compared to analysts’ expectations of $0.10 million. Helius Medical Technologies updated its FY 2020 After-Hours guidance to EPS. OTCMKTS HSDT opened at $0.47 on Friday. Helius Medical Technologies has a 12 month low of $0.28 and a 12 month high of $7.14 …

Neuromodulation Industry Outlook, 2020-2025: An $8.8 Billion Opportunity Assessment with Profiles of Leading Market Players | PR Newswire | 3/13/2020

… Neurosigma, Inc. 10.7 Neuropace, Inc. 10.8 Biocontrol Medical 10.9 Synapse Biomedical 10.10 Neuronetics 10.11 Bioness 10.12 Soterix Medical 10.13 Integer Holdings Corporation 10.14 Bioinduction 10.15 Other Players 10.15.1 Gimer Medical 10.15.2 GTX Medical 10.15.3 Helius Medical Technologies 10.15.4 Microtransponder 10.15.5 Neuronano 10.15.6 Bluewind Medical For more information about this report visit https://www.researchandmarkets.com/r/hfy70t Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media …

Helius Medical Technologies (OTCMKTS:HSDT) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS | 3/13/2020

… share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.21) by $0.02, Bloomberg Earnings reports. The company had revenue of $0.15 million for the quarter, compared to analyst estimates of $0.10 million. Helius Medical Technologies updated its FY 2020 After-Hours guidance to EPS. Shares of HSDT traded down $0.04 during mid-day trading on Friday, reaching $0.46. 166,222 shares of the company’s stock were exchanged, compared to …

Helius Medical Technologies EPS beats by $0.02, misses on revenue - Helius Medical Technologies, Inc. (NASDAQ:HSDT) | Seeking Alpha | 3/12/2020

Helius Medical Technologies (NASDAQ: HSDT ): Q4 GAAP EPS of -$0.19 beats by $0.02 . Revenue of $0.15M (-68.8% Y/Y) misses by $0.05M . Press Release Click to subscribe to real-time analytics on HSDT Now read: Savara EPS misses by $0.31 …

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Introduces Full Year 2020 Outlook | Globe Newswire | 3/12/2020

NEWTOWN, Pa., March 12, Helius Medical Technologies , Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter and full year ended December 31, 2019. Full Year 2019 Financial Summary Revenue of $1.5 million, compared to revenue of $0.5 million in 2018. Total revenue comprised of: Product sales of $1.454 million, compared to no product sales in 2018 …

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment™ Clinics | Globe Newswire | 3/9/2020

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment™ Clinics Expands Access to PoNS Treatment™ in the Greater Toronto Area and Southwestern Ontario March 09, 2020 07:05 ET Source: Helius Medical Technologies , Inc. NEWTOWN, Pa., Helius Medical Technologies , Inc. (Nasdaq: HSDT) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today provided details on five additional PoNS Treatment™ clinics that were recently authorized …

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment Clinics | Financial Buzz | 3/9/2020

NEWTOWN, Pa., Helius Medical Technologies , Inc. (Nasdaq: HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today provided details on five additional PoNS Treatment™ clinics that were recently authorized in the Greater Toronto Area and Southwestern Ontario. Helius has now expanded access for patients seeking PoNS Treatment to fourteen clinics in Canada, with eight in Ontario, the most populous province. “Our progress in authorizing seven …

Helius Medical Technologies (OTCMKTS:HSDT) Shares Pass Below Fifty Day Moving Average of $1.00 - WKRB News | 3/8/2020

Shares of Helius Medical Technologies Inc (OTCMKTS:HSDT) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.00 and traded as low as $0.71. Helius Medical Technologies shares last traded at $0.74, with a volume of 37,466 shares trading hands. Separately, Zacks Investment Research upgraded shares of Helius Medical Technologies from a “sell” rating to a “hold” rating in …

Helius Medical Technologies Reports Preliminary Unaudited Fourth Quarter and Full Year Unaudited 2019 Financial Results, Provides Commercial and Regulatory Update and Announces Submission to Health Canada for Multiple Sclerosis (MS) Label Expansion and New US Regulatory Prioritization for MS | Globe Newswire | 3/2/2020

NEWTOWN, Pa., March 02, 2020 (GLOBE NEWSWIRE) – Helius Medical Technologies , Inc. (NASDAQ: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2019, provided an update on its commercial and regulatory activities and announced it has submitted a Canadian Class II license amendment application for the treatment of gait deficit …

Clinical Data

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher | Benzinga | 11/13/2019

clinical data for ALPN-101 in inflammatory/autoimmune diseases) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) Capricor Therapeutics Inc (NASDAQ: CAPR Cellectar Biosciences Inc (NASDAQ: CLRB ) )(reacted to its third-quarter results) CNS Pharmaceuticals Inc (NASDAQ: CNSP ) Cocrystal Pharma Inc (NASDAQ: COCP )(reacted to its third-quarter results) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Genocea Biosciences Inc (NASDAQ: GNCA ) Helius Medical Technologies

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Helius Medical Technologies, Inc. | Business Wire | 7/17/2019

… 9, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) securities between November 9, 2017 … the PoNS device because the Company had not provided sufficient clinical data to show the device was effective. On this news, shares of Helius fell $4.11, or more than 66%, to close at $2.10 per …

Biotech

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher | Benzinga | 11/13/2019

Here’s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE … Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Genocea Biosciences Inc (NASDAQ: GNCA ) Helius Medical Technologies Inc (NASDAQ: HSDT )(reported its third-quarter results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Kezar Life Sciences Inc (NASDAQ: KZR ) Miragen Therapeutics Inc …

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera’s Reverse Split, 2 Biotechs To Debut | Benzinga | 11/8/2019

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 7.) Collegium Pharmaceutical Inc (NASDAQ: COLL ) (reacted … Pharma Inc (NASDAQ: COCP ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Helius Medical Technologies Inc (NASDAQ: HSDT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Iterum Therapeutics PLC (NASDAQ: ITRM ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) Mirum Pharmaceuticals Inc …

Healthtech

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook | Globe Newswire | 11/12/2019

November 12, 2019 07:00 ET Source: Helius Medical Technologies, Inc. NEWTOWN, Pa., Nov. 12, Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported … October 30, 2019, the Company entered into an agreement with HealthTech Connex Inc (“HTC”), the Company’s commercial development partner in Canada, to purchase Heuro Canada, Inc. (“Heuro”). “During the third quarter, we continued to make …

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook | BioSpace | 11/12/2019

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook Published: Nov 12, 2019 NEWTOWN, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq … October 30, 2019, the Company entered into an agreement with HealthTech Connex Inc (“HTC”), the Company’s commercial development partner in Canada, to purchase Heuro Canada, Inc. (“Heuro”). “During the third quarter, we continued to make …

Food and Drug Administration

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook | Globe Newswire | 11/12/2019

November 12, 2019 07:00 ET Source: Helius Medical Technologies, Inc. NEWTOWN, Pa., Nov. 12, Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported … regulatory strategy following its pre-submission meeting with the U.S. Food and Drug Administration (“FDA”) On October 30, 2019, the Company entered into an agreement with HealthTech Connex Inc (“HTC”), the Company’s commercial development partner …

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook | BioSpace | 11/12/2019

Helius Medical Technologies, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update; Updates Full Year 2019 Outlook Published: Nov 12, 2019 NEWTOWN, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) – Helius Medical Technologies, Inc. (Nasdaq … regulatory strategy following its pre-submission meeting with the U.S. Food and Drug Administration (“FDA”) On October 30, 2019, the Company entered into an agreement with HealthTech Connex Inc (“HTC”), the Company’s commercial development partner …

Medtronic

Neuromodulation Industry Outlook, 2020-2025: An $8.8 Billion Opportunity Assessment with Profiles of Leading Market Players | PR Newswire | 3/13/2020

… the dearth of a trained workforce, will challenge market growth. The prominent players operating in the global neuromodulation market include Medtronic ( Ireland ), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro … 10.15 Other Players 10.15.1 Gimer Medical 10.15.2 GTX Medical 10.15.3 Helius Medical Technologies 10.15.4 Microtransponder 10.15.5 Neuronano 10.15.6 Bluewind Medical For more information about this report visit https://www.researchandmarkets.com/r/hfy70t Research and Markets also …

Neurostimulation Devices Market Set to Record a CAGR of 10.23% Over 2019-2027 - High Market Potential for SCS Devices in Neurostimulation Presents Lucrative Opportunities | PR Newswire | 1/22/2020

Medtronic plc, Hocoma AG, Helius Medical Technologies, and The Magstim Company Limited. Key Topics Covered 1. Global Neurostimulation Device Market - Summary 2. Industry Outlook 2.1. Market Definition 2.2. Porter’s Five Forces Model 2.3. Value Chain Outlook 2.4. Market Trends 2.5. Market Share Outlook 2.6. PESTLE Outlook 2.7. Market Attractiveness Index 2.8. Key Insight 2.9. Market Drivers 2.9.1. Rising Incidence of Neuro Diseases 2.9.2. Increasing Geriatric Population 2.9.3. Growing Demand for …

Seattle Genetics

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher | Benzinga | 11/13/2019

… GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd … Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Genocea Biosciences Inc (NASDAQ: GNCA ) Helius Medical Technologies Inc (NASDAQ: HSDT )(reported its third-quarter results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Kezar Life Sciences Inc (NASDAQ: KZR ) Miragen Therapeutics Inc …

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst’s Edema Drug In Japan, Myriad’s Q1 Disappointment | Benzinga | 11/5/2019

Helius Medical Technologies Inc (NASDAQ: HSDT ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) Rockwell Medical Inc (NASDAQ: RMTI ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Stocks In Focus Seattle Genetics Claims Rights To Disputed Antibody-Drug Conjugate Intellectual Property Following the filing of a declaratory judgment action by DAIICHI SANKYO/S ADR (OTC: DSNKY ), Seattle Genetics, Inc. (NASDAQ: SGEN ) said the antibody-drug conjugate tech used in Daiichi …

Vertex Pharmaceuticals

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher | Benzinga | 11/13/2019

… Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) XOMA Corp (NASDAQ … Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Genocea Biosciences Inc (NASDAQ: GNCA ) Helius Medical Technologies Inc (NASDAQ: HSDT )(reported its third-quarter results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Kezar Life Sciences Inc (NASDAQ: KZR ) Miragen Therapeutics Inc …

The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings | 10/30/2019

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 29) Acorda Therapeutics Inc (NASDAQ: ACOR ) Agile Therapeutics Inc (NASDAQ: AGRX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) Axcella Health Inc (NASDAQ: AXLA ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Helius Medical Technologies Inc (NASDAQ: HSDT ) Hoth Therapeutics Inc (NASDAQ: HOTH …

Amgen

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher | Benzinga | 11/13/2019

… The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bio … Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Genocea Biosciences Inc (NASDAQ: GNCA ) Helius Medical Technologies Inc (NASDAQ: HSDT )(reported its third-quarter results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Kezar Life Sciences Inc (NASDAQ: KZR ) Miragen Therapeutics Inc …

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst’s Edema Drug In Japan, Myriad’s Q1 Disappointment | Benzinga | 11/5/2019

… 52-week highs on Nov. 4) Agile Therapeutics Inc (NASDAQ: AGRX )(follow-on rally following positive Adcom verdict for Twirla) Amgen, Inc. (NASDAQ: AMGN ) Beigene Ltd (NASDAQ: BGNE ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Bio-Rad … week lows on Nov. 4) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Helius Medical Technologies Inc (NASDAQ: HSDT ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) Rockwell Medical Inc (NASDAQ: RMTI ) Tetraphase Pharmaceuticals Inc …

Karyopharm Therapeutics

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher | Benzinga | 11/13/2019

… DRNA ) DexCom, Inc. (NASDAQ: DXCM ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Galera Therapeutics Inc (NASDAQ: GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX … Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Genocea Biosciences Inc (NASDAQ: GNCA ) Helius Medical Technologies Inc (NASDAQ: HSDT )(reported its third-quarter results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Kezar Life Sciences Inc (NASDAQ: KZR ) Miragen Therapeutics Inc …

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), SPDR S&P Biotech ETF (ETF:XBI) - The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings | Benzinga | 11/6/2019

… Laboratories, Inc. (NYSE: BIO ) Constellation Pharmaceuticals Inc (NASDAQ: CNST ) Fulgent Genetics Inc (NASDAQ: FLGT ) ( reported forecast-beating third-quarter results) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) NextCure Inc (NASDAQ: NXTC ) (made a huge move ahead of … 52-week lows Nov. 5.) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Helius Medical Technologies Inc (NASDAQ: HSDT ) Homology Medicines Inc (NASDAQ: FIXX ) Kezar Life Sciences Inc (NASDAQ: KZR ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Myriad Genetics, Inc …

MiMedx

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intelligent Systems, Helius Medical, Verb Technology, and CannTrust and Encourages Investors to Contact the Firm | Globe Newswire | 8/31/2019

… P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Intelligent Systems Corporation (NYSE: INS), Helius Medical Technologies, Inc. (NASDAQ: HASDT), Verb Technology Company, Inc. (NASDAQ: VERB), and CannTrust Holdings … Audit Committee engaged in accounting fraud as the CEO of MiMedx Group, Inc.; (2) Intelligent Systems’ CEO, Defendant Strange, engaged in undisclosed related-party transactions with Defendant Petit and others and had an undisclosed personal …

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intelligent Systems, Helius Medical, Verb Technology, and CannTrust and Encourages Investors to Contact the Firm | Globe Newswire | 8/31/2019

… P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Intelligent Systems Corporation (NYSE: INS), Helius Medical Technologies, Inc. (NASDAQ: HASDT), Verb Technology Company, Inc. (NASDAQ: VERB), and CannTrust Holdings … Audit Committee engaged in accounting fraud as the CEO of MiMedx Group, Inc.; (2) Intelligent Systems’ CEO, Defendant Strange, engaged in undisclosed related-party transactions with Defendant Petit and others and had an undisclosed personal …

Teva Pharmaceutical

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm | 7/17/2019

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros International Plc, Teva Pharmaceutical **Industries Ltd, and **Helius Medical Technologies, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Pivotal Software, Inc …

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm | Benzinga | 7/17/2019

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) – Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros International Plc, Teva Pharmaceutical **Industries Ltd, and **Helius Medical Technologies, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Pivotal Software, Inc …

Teva Pharmaceutical

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm | 7/17/2019

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros International Plc, Teva Pharmaceutical Industries Ltd, and Helius Medical Technologies, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Pivotal Software, Inc …

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Eros International, Teva Pharmaceutical Industries, and Helius Medical Technologies and Encourages Investors to Contact the Firm | Benzinga | 7/17/2019

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) – Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pivotal Software, Inc., Eros International Plc, Teva Pharmaceutical Industries Ltd, and Helius Medical Technologies, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Pivotal Software, Inc …

Zacks Equity Research

Helius Medical Technologies, Inc. (HSDT) Reports Q3 Loss, Misses Revenue Estimates | Zacks | 11/12/2019

You follow Tale of the Tape - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide Full Article Helius Medical Technologies, Inc. ( HSDT - Free Report ) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring …

Helius Medical Technologies, Inc. (HSDT) Reports Q3 Loss, Misses Revenue Estimates | Yahoo News | 11/12/2019

Helius Medical Technologies, Inc. (HSDT) Reports Q3 Loss, Misses Revenue Estimates Zacks Equity Research Reblog Helius Medical Technologies, Inc. (HSDT) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of …

Health Net

Edited Transcript of HSM.TO earnings conference call or presentation 12-Mar-20 9:00pm GMT | 3/29/2020

… Operator [1] Good evening, ladies and gentlemen. And welcome to the Fourth Quarter Fiscal Year 2019 Earnings Conference Call for Helius Medical Technologies. (Operator Instructions) Please note this conference call is being recorded and that … the Toronto Rehabilitation Institute and a member of the University Health Network or UHN. Let me provide you with a quick agenda for today’s call. We’ll begin by having Dr. Kalsi-Ryan, provide you with …

Edited Transcript of HSM.TO earnings conference call or presentation 12-Mar-20 9:00pm GMT | 3/29/2020

… Operator [1] Good evening, ladies and gentlemen. And welcome to the Fourth Quarter Fiscal Year 2019 Earnings Conference Call for Helius Medical Technologies. (Operator Instructions) Please note this conference call is being recorded and that … the Toronto Rehabilitation Institute and a member of the University Health Network or UHN. Let me provide you with a quick agenda for today’s call. We’ll begin by having Dr. Kalsi-Ryan, provide you with …

Bragar Eagel

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Helius Medical Technologies (NASDAQ: HSDT) and Encourages Helius Investors to Contact the Firm | Business Wire | 9/7/2019

Bragar Eagel & Squire, P.C. announces that a has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Helius Medical Technologies, Inc. (NASDAQ: HSDT) securities between November 9, 2017 and April 10, 2019 (“the “Class Period”). Investors have until September 9, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here …

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Helius Medical Technologies (NASDAQ: HSDT) and Encourages Helius Investors to Contact the Firm | Benzinga | 9/7/2019

Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Helius Medical Technologies, Inc. (NASDAQ: HSDT ) securities between November 9, 2017 and April 10, 2019 (“the “Class Period”). Investors have until September 9, 2019 to apply to the Court to be appointed as lead plaintiff in the …

Robert S. Willoughby

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Helius Medical Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline - HSDT | Globe Newswire | 9/7/2019

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP announces that a class action lawsuit has been filed against Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT) and certain of its officers. The … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Helius Medical Technologies, Inc. of Class Action Lawsuit and Upcoming Deadline - HSDT | Globe Newswire | 8/29/2019

… 2019 12:25 ET Source: Pomerantz LLP NEW YORK, Pomerantz LLP announces that a class action lawsuit has been filed against Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT) and certain of its officers … can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include …

Phillip Kim

ROSEN, A TOP RANKED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important Monday Deadline in Securities Class Action – HSDT | Globe Newswire | 9/5/2019

… Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10, 2019, inclusive (the “Class Period”), of the important September 9, 2019 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Helius investors under the federal securities laws. To join the Helius class action, go to https://www.rosenlegal.com/cases-register-1496.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or …

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important September 9th Deadline in Securities Class Action; Investors with Losses in Excess of $100K Are Encouraged to Contact the Firm – HSDT | Globe Newswire | 8/28/2019

… Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10, 2019, inclusive (the “Class Period”), of the important September 9, 2019 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Helius investors under the federal securities laws. To join the Helius class action, go to https://www.rosenlegal.com/cases-register-1496.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or …

Lesley Portnoy

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Helius Medical Technologies, Inc. | Globe Newswire | 9/4/2019

… Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) investors who purchased securities between November 9, 2017 and April 10, 2019 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley …

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Helius Medical Technologies, Inc. | Globe Newswire | 9/3/2019

… Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) investors who purchased securities between November 9, 2017 and April 10, 2019 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley …

Howard G. Smith

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Helius Medical Technologies, Inc. | 9/3/2019

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Helius Medical Technologies, Inc. Posted on 09/03/2019 50 BENSALEM, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) — Law Offices of Howard G. Smith reminds investors of the upcoming September 9, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Helius Medical Technologies

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Helius Medical Technologies, Inc. | Globe Newswire | 9/3/2019

September 03, 2019 14:43 ET Source: Law Offices of Howard G. Smith BENSALEM, Pa., Sept. 03, 2019 (GLOBE NEWSWIRE) – Law Offices of Howard G. Smith reminds investors of the upcoming September 9, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) securities between November 9, 2017 and April 10, 2019 …

Peretz Bronstein

Helius Medical Technologies, Inc. (HSDT), Ideanomics Inc. (IDEX) & Netflix, Inc. (NFLX) –Bronstein, Gewirtz & Grossman, LLC - Class Action Update | Globe Newswire | 8/23/2019

… publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC … future recovery is not dependent upon serving as lead plaintiff. Helius Medical Technologies, Inc. (NASDAQ: HSDT) Class Period: November 9, 2017 - April 10, 2019 Deadline: September 9, 2019 For more info: www.bgandg.com/hsdt The complaint …

Helius Medical Technologies, Inc. (HSDT), Ideanomics Inc. (IDEX) & Netflix, Inc. (NFLX) – Class Action Reminder - Bronstein, Gewirtz & Grossman, LLC | Globe Newswire | 8/16/2019

… publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC … future recovery is not dependent upon serving as lead plaintiff. Helius Medical Technologies, Inc. (NASDAQ: HSDT) Class Period: November 9, 2017 - April 10, 2019 Deadline: September 9, 2019 For more info: www.bgandg.com/hsdt The complaint …

Yael Hurwitz

Helius Medical Technologies, Inc. (HSDT), Ideanomics Inc. (IDEX) & Netflix, Inc. (NFLX) –Bronstein, Gewirtz & Grossman, LLC - Class Action Update | Globe Newswire | 8/23/2019

… of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 . If you suffered a loss, you … future recovery is not dependent upon serving as lead plaintiff. Helius Medical Technologies, Inc. (NASDAQ: HSDT) Class Period: November 9, 2017 - April 10, 2019 Deadline: September 9, 2019 For more info: www.bgandg.com/hsdt The complaint …

Helius Medical Technologies, Inc. (HSDT), Ideanomics Inc. (IDEX) & Netflix, Inc. (NFLX) – Class Action Reminder - Bronstein, Gewirtz & Grossman, LLC | Globe Newswire | 8/16/2019

… of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 . If you suffered a loss, you … future recovery is not dependent upon serving as lead plaintiff. Helius Medical Technologies, Inc. (NASDAQ: HSDT) Class Period: November 9, 2017 - April 10, 2019 Deadline: September 9, 2019 For more info: www.bgandg.com/hsdt The complaint …

Brian Schall

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Globe Newswire | 8/5/2019

… ANGELES, The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Helius Medical Technologies, Inc. (“Helius” or “the Company”) (NASDAQ: HSDT) for violations of §§10(b … click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of …

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Helius Medical Technologies, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | Globe Newswire | 7/29/2019

… NEWSWIRE) – The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Helius Medical Technologies, Inc. (“Helius” or “the Company”) (NASDAQ: HSDT ) for violations of §§10(b … click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of …

Abraham L. Pomerantz

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Helius Medical Technologies, Inc. - HSDT | Globe Newswire | 7/31/2019

… July 31, 2019 13:28 ET Source: Pomerantz LLP NEW YORK, Pomerantz LLP is investigating claims on behalf of investors of Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT). Such investors are advised to … corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than …

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Helius Medical Technologies, Inc. - HSDT | Globe Newswire | 7/26/2019

… Source: Pomerantz LLP NEW YORK, July 25, 2019 (GLOBE NEWSWIRE) – Pomerantz LLP is investigating claims on behalf of investors of Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT). Such investors are advised to … corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than …

Laurence Rosen

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Helius Medical Technologies, Inc. - HSDT | Markets Insider | Business Insider | 7/18/2019

… investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10 , 2019, inclusive … secured hundreds of millions of dollars for investors. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34 th Floor New York, NY 10016 Tel: (212) 686-1060 Toll …

ROSEN, A TOP RANKED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important Deadline in Securities Class Action – HSDT | Business Wire | 7/15/2019

… BUSINESS WIRE)–Jul 15, 2019– Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Helius Medical Technologies, Inc. (NASDAQ: HSDT) from November 9, 2017 through April 10, 2019, inclusive … version on businesswire.com : https://www.businesswire.com/news/home/20190715005756/en/ CONTACT: Laurence Rosen, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34thFloor …